Clinical Trials Insight: 700027249
Phase of Trial: Phase I
Latest Information Update: 12 May 2008
At a glance
- Drugs VEL 0230 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Velcura Therapeutics
- 12 May 2008 Status changed to completed (source: Velcura Therapeutics media release).
- 02 Oct 2007 New trial record.